CD4 counts were available for most of the TB-positive HIV-positive subjects and included subjects above and below the 100 cells/μl threshold used in the WHO algorithm for identifying immunocompromised patients most likely to benefit from the Alere LF-LAM test. The gene discussed is CD4; the disease is tuberculosis.